211 related articles for article (PubMed ID: 14568968)
21. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
22. Role of CXCR3-induced donor T-cell migration in acute GVHD.
Duffner U; Lu B; Hildebrandt GC; Teshima T; Williams DL; Reddy P; Ordemann R; Clouthier SG; Lowler K; Liu C; Gerard C; Cooke KR; Ferrara JL
Exp Hematol; 2003 Oct; 31(10):897-902. PubMed ID: 14550805
[TBL] [Abstract][Full Text] [Related]
23. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.
Delisle JS; Gaboury L; Bélanger MP; Tassé E; Yagita H; Perreault C
Blood; 2008 Sep; 112(5):2111-9. PubMed ID: 18552211
[TBL] [Abstract][Full Text] [Related]
25. T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.
Fu J; Wu Y; Nguyen H; Heinrichs J; Schutt S; Liu Y; Liu C; Jin J; Anasetti C; Yu XZ
J Immunol; 2016 Apr; 196(7):3168-79. PubMed ID: 26903480
[TBL] [Abstract][Full Text] [Related]
26. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
[TBL] [Abstract][Full Text] [Related]
28. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
Kim JH; Choi EY; Chung DH
J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
Williamson E; Garside P; Bradley JA; More IA; Mowat AM
J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
[TBL] [Abstract][Full Text] [Related]
30. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease.
Chen F; Maldonado MA; Madaio M; Eisenberg RA
J Immunol; 1998 Dec; 161(11):5880-5. PubMed ID: 9834067
[TBL] [Abstract][Full Text] [Related]
31. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
[TBL] [Abstract][Full Text] [Related]
32. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
33. Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.
Welniak LA; Blazar BR; Anver MR; Wiltrout RH; Murphy WJ
Biol Blood Marrow Transplant; 2000; 6(6):604-12. PubMed ID: 11128810
[TBL] [Abstract][Full Text] [Related]
34. CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.
Park HB; Oh K; Garmaa N; Seo MW; Byoun OJ; Lee HY; Lee DS
Transplantation; 2010 Oct; 90(8):825-35. PubMed ID: 20697326
[TBL] [Abstract][Full Text] [Related]
35. Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.
Oh I; Ozaki K; Meguro A; Hatanaka K; Kadowaki M; Matsu H; Tatara R; Sato K; Iwakura Y; Nakae S; Sudo K; Teshima T; Leonard WJ; Ozawa K
J Immunol; 2010 Aug; 185(3):1920-6. PubMed ID: 20574002
[TBL] [Abstract][Full Text] [Related]
36. IL-17 contributes to CD4-mediated graft-versus-host disease.
Kappel LW; Goldberg GL; King CG; Suh DY; Smith OM; Ligh C; Holland AM; Grubin J; Mark NM; Liu C; Iwakura Y; Heller G; van den Brink MR
Blood; 2009 Jan; 113(4):945-52. PubMed ID: 18931341
[TBL] [Abstract][Full Text] [Related]
37. Role of CD28 in acute graft-versus-host disease.
Yu XZ; Martin PJ; Anasetti C
Blood; 1998 Oct; 92(8):2963-70. PubMed ID: 9763584
[TBL] [Abstract][Full Text] [Related]
38. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
39. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.
Serody JS; Cook DN; Kirby SL; Reap E; Shea TC; Frelinger JA
Blood; 1999 Jan; 93(1):43-50. PubMed ID: 9864144
[TBL] [Abstract][Full Text] [Related]
40. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
